124 related articles for article (PubMed ID: 10544564)
1. [The immunodiagnosis of breast cancer metastases to the bone marrow].
Sarkisian GP; Bulycheva TI; Kudinov IuA
Klin Lab Diagn; 1999 Aug; (8):21. PubMed ID: 10544564
[TBL] [Abstract][Full Text] [Related]
2. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow micrometastases and adjuvant treatment of breast cancer.
Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
[TBL] [Abstract][Full Text] [Related]
4. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?
Trocciola SM; Hoda S; Osborne MP; Christos PJ; Levin H; Martins D; Carson J; Daly J; Simmons RM
J Am Coll Surg; 2005 May; 200(5):720-5; discussion 725-6. PubMed ID: 15848362
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.
Layer G; Steudel A; Schüller H; van Kaick G; Grünwald F; Reiser M; Schild HH
Cancer; 1999 Feb; 85(4):1004-9. PubMed ID: 10091781
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy or detection of micrometastasis in bone marrow: which might be an alternative to axillary lymph node dissection in breast cancer patients?
Zhu L; Lam CK; Chow LW
Asian J Surg; 2004 Oct; 27(4):279-83. PubMed ID: 15564179
[TBL] [Abstract][Full Text] [Related]
8. [Cytokeratin-19 in diagnosis of bone marrow metastases in patients with breast cancer - clinical results].
Iovtchev I; Gŭlŭbova M; Vlaĭkova T; Vidolov P
Khirurgiia (Sofiia); 2007; (3):43-5. PubMed ID: 18437110
[TBL] [Abstract][Full Text] [Related]
9. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors.
Gerber B; Krause A; Müller H; Richter D; Reimer T; Makovitzky J; Herrnring C; Jeschke U; Kundt G; Friese K
J Clin Oncol; 2001 Feb; 19(4):960-71. PubMed ID: 11181658
[TBL] [Abstract][Full Text] [Related]
12. Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes.
Crump M; Goss PE; Prince M; Girouard C
J Clin Oncol; 1996 Jan; 14(1):66-9. PubMed ID: 8558222
[TBL] [Abstract][Full Text] [Related]
13. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
Cabioglu N; Sahin A; Doucet M; Yavuz E; Igci A; O Yildirim E; Aktas E; Bilgic S; Kiran B; Deniz G; Price JE
Clin Exp Metastasis; 2005; 22(1):39-46. PubMed ID: 16132577
[TBL] [Abstract][Full Text] [Related]
15. Combined sentinel lymph-node mapping and bone-marrow micrometastatic analysis for improved staging in breast cancer.
Relihan N; McGreal G; Kelly J; Ryan D; O'Sullivan GC; Redmond HP
Lancet; 1999 Jul; 354(9173):129-30. PubMed ID: 10408494
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.
Lucci A; Krishnamurthy S; Singh B; Bedrosian I; Meric-Bernstam F; Reuben J; Broglio K; Mosalpuria K; Lodhi A; Vincent L; Cristofanilli M
Breast Cancer Res Treat; 2009 Sep; 117(1):61-8. PubMed ID: 18663571
[TBL] [Abstract][Full Text] [Related]
17. Occult metastases in patients with breast cancer.
Hawes D; Neville AM; Cote RJ
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):60S-63S. PubMed ID: 11599903
[TBL] [Abstract][Full Text] [Related]
18. Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow.
Bomken SN; Redfern K; Wood KM; Reid MM; Tweddle DA
J Clin Pathol; 2006 Sep; 59(9):927-9. PubMed ID: 16565222
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
20. Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients.
Schadendorf D; Dorn-Beineke A; Borelli S; Riethmuller G; Pantel K
Exp Dermatol; 2003 Apr; 12(2):165-71. PubMed ID: 12702145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
